Literature DB >> 22661396

Clinical features and diagnostic significance of the intraocular fluid of 217 patients with intraocular lymphoma.

Keisuke Kimura1, Yoshihiko Usui, Hiroshi Goto.   

Abstract

PURPOSE: Intraocular lymphoma is a rare disease with a poor prognosis. Early diagnosis and early treatment greatly influence the survival prognosis of this disease. This retrospective study aimed to clarify the clinical features of patients diagnosed with intraocular lymphoma, and the diagnostic significance of results from analysis of vitreous samples including cytology, cytokine measurements, and the IgH gene rearrangement test.
METHODS: We reviewed 217 patients with intraocular lymphoma diagnosed at 25 medical institutions in Japan. Together with clinical observation, cytological analysis, determination of the levels of cytokines, and/or detection of IgH gene rearrangements were conducted using vitreous fluid specimens. The results were studied in conjunction with clinical findings of intraocular lymphoma. Survival curves were estimated by use of the Kaplan-Meier method.
RESULTS: The subjects comprised 85 men and 132 women, with a mean age at first ophthalmological examination of 63.4 years. The mean observation period was 41.3 months. During the observation period, 69 patients had onset of lymphoma in one eye and 148 had onset in both eyes. Intraocular lymphoma with involvement of the central nervous system (CNS) was most common, found in 60.8 % of the patients, whereas intraocular lymphoma without involvement of other organs was found in 28.1 % of patients. With respect to onset patterns, 82.5 % of patients developed primary ocular lesions whereas 16.1 % developed primary CNS lesions preceding intraocular lymphoma. Blurred vision and ataxia were the most common ocular and extra-ocular symptoms that prompted patients to seek medical examination. Vitreous opacification was the most common ocular finding. The detection rates of malignant cytology, IL-10/IL-6 ratio greater than 1.0, and IgH gene rearrangements in vitreous specimens were 44.5, 91.7, and 80.6 %, respectively, of patients tested. IL-10/IL-6 ratio greater than 1.0 had the highest overall detection rate, and was extremely high (≥90 %) in patients with or without vitreous opacification. The 5-year survival rate was 61.1 %.
CONCLUSION: Cytokine analysis of vitreous biopsy had the highest detection rate for intraocular lymphoma. This supplementary diagnostic test should be performed frequently to confirm a diagnosis of intraocular lymphoma.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22661396     DOI: 10.1007/s10384-012-0150-7

Source DB:  PubMed          Journal:  Jpn J Ophthalmol        ISSN: 0021-5155            Impact factor:   2.447


  31 in total

1.  Intraocular reticulum cell sarcoma. Diagnosis by pars plana vitrectomy.

Authors:  R G Michels; D L Knox; Y S Erozan; W R Green
Journal:  Arch Ophthalmol       Date:  1975-12

2.  Vitreous cytokine levels.

Authors:  Lesley A Wolf; George F Reed; Ronald R Buggage; Robert B Nussenblatt; Chi-Chao Chan
Journal:  Ophthalmology       Date:  2003-08       Impact factor: 12.079

3.  Malignant lymphoma of the uveal tract.

Authors:  E L COOPER; J L RIKER
Journal:  Am J Ophthalmol       Date:  1951-08       Impact factor: 5.258

4.  Treatment of primary intraocular lymphoma with radiation therapy: a multi-institutional survey in Japan.

Authors:  Koichi Isobe; Yasuo Ejima; Sunao Tokumaru; Naoto Shikama; Gen Suzuki; Mitsuhiro Takemoto; Emiko Tsuchida; Miwako Nomura; Yuta Shibamoto; Naofumi Hayabuchi
Journal:  Leuk Lymphoma       Date:  2006-09

5.  Ocular reticulum cell sarcoma.

Authors:  T G Klingele; M J Hogan
Journal:  Am J Ophthalmol       Date:  1975-01       Impact factor: 5.258

6.  Epidemiology of primary CNS lymphoma.

Authors:  M Schabet
Journal:  J Neurooncol       Date:  1999-07       Impact factor: 4.130

7.  Primary intraocular lymphoma (ocular reticulum cell sarcoma) diagnosis and management.

Authors:  D H Char; B M Ljung; T Miller; T Phillips
Journal:  Ophthalmology       Date:  1988-05       Impact factor: 12.079

8.  Intraocular lymphoma 2000-2005: results of a retrospective multicentre trial.

Authors:  Kristoph Jahnke; Agnieszka Korfel; Julia Komm; Nikolaos E Bechrakis; Harald Stein; Eckhard Thiel; Sarah E Coupland
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-10-16       Impact factor: 3.117

9.  Primary CNS lymphoma with intraocular involvement: International PCNSL Collaborative Group Report.

Authors:  S A Grimm; C A McCannel; A M P Omuro; A J M Ferreri; J-Y Blay; E A Neuwelt; T Siegal; T Batchelor; K Jahnke; T N Shenkier; A J Hall; F Graus; U Herrlinger; D Schiff; J Raizer; J Rubenstein; N Laperriere; E Thiel; N Doolittle; F M Iwamoto; L E Abrey
Journal:  Neurology       Date:  2008-10-21       Impact factor: 9.910

10.  Biological diagnosis of primary intraocular lymphoma.

Authors:  Hélène Merle-Béral; Frédéric Davi; Nathalie Cassoux; Sylvie Baudet; Chantal Colin; Thomas Gourdet; Bahram Bodaghi; Phuc LeHoang
Journal:  Br J Haematol       Date:  2004-02       Impact factor: 6.998

View more
  61 in total

1.  Gradient Boosted Decision Tree Classification of Endophthalmitis Versus Uveitis and Lymphoma from Aqueous and Vitreous IL-6 and IL-10 Levels.

Authors:  David E Kuo; Maggie M Wei; Karen R Armbrust; Jared E Knickelbein; Ian Y L Yeung; Robert B Nussenblatt; Chi-Chao Chan; Hatice Nida Sen
Journal:  J Ocul Pharmacol Ther       Date:  2017-02-03       Impact factor: 2.671

2.  Risk factors for failure of vitrectomy cell block technique in cytological diagnosis of vitreoretinal lymphoma.

Authors:  Takako Ito; Atsunobu Takeda; Kohta Fujiwara; Eiichi Hasegawa; Shintaro Nakao; Yoshihiro Ohishi; Yoshinao Oda; Hiroshi Yoshikawa; Koh-Hei Sonoda
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-03-13       Impact factor: 3.117

Review 3.  Current concepts in diagnosing and managing primary vitreoretinal (intraocular) lymphoma.

Authors:  Chi-Chao Chan; H Nida Sen
Journal:  Discov Med       Date:  2013-02       Impact factor: 2.970

4.  Diagnostic value of interleukin-10 in cerebrospinal fluid for diffuse large B-cell lymphoma of the central nervous system.

Authors:  Yasuo Sasagawa; Takuya Akai; Osamu Tachibana; Hideaki Iizuka
Journal:  J Neurooncol       Date:  2014-09-26       Impact factor: 4.130

5.  25-gauge transconjunctival diagnostic vitrectomy in suspected cases of intraocular lymphoma: a case series and review of the literature.

Authors:  Mozhgan Rezaei Kanavi; Masoud Soheilian; Sayed Bagher Hosseini; Amir A Azari
Journal:  Int J Ophthalmol       Date:  2014-06-18       Impact factor: 1.779

Review 6.  Diagnostic vitrectomy for primary intraocular lymphoma: when, why, how?

Authors:  Cindy S Hwang; Steven Yeh; Chris S Bergstrom
Journal:  Int Ophthalmol Clin       Date:  2014

7.  [Primary vitreoretinal lymphoma].

Authors:  D Jaehne; S E Coupland
Journal:  Ophthalmologe       Date:  2018-04       Impact factor: 1.059

8.  Measurement of interleukins in vitreous infusion fluid.

Authors:  Satoru Kase; Masahiko Yokoi; Susumu Ishida; Manabu Kase
Journal:  Biomed Rep       Date:  2015-08-26

Review 9.  Intraocular lymphoma.

Authors:  Li-Juan Tang; Chang-Lin Gu; Ping Zhang
Journal:  Int J Ophthalmol       Date:  2017-08-18       Impact factor: 1.779

10.  Logistic Regression Classification of Primary Vitreoretinal Lymphoma versus Uveitis by Interleukin 6 and Interleukin 10 Levels.

Authors:  David E Kuo; Maggie M Wei; Jared E Knickelbein; Karen R Armbrust; Ian Y L Yeung; Aaron Y Lee; Chi-Chao Chan; H Nida Sen
Journal:  Ophthalmology       Date:  2020-02-05       Impact factor: 12.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.